Conformal Radiotherapy Facilitates the Delivery of Concurrent Chemotherapy and Radiotherapy: A Case of Primitive Neuroectodermal Tumour of the Chest Wall

por Coles, C. E., Twyman, N., Earl, H. M., Burnet, N. G.
Publicado 2000

A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian...

por Kehoe, S., Poole, C. J., Stanley, A., Earl, H. M., Blackledge, G. R.
Publicado 1994

Patients at risk of chemotherapy-associated toxicity in small cell lung cancer.

por Morittu, L., Earl, H. M., Souhami, R. L., Ash, C. M., Tobias, J. S., Geddes, D. M., Harper, P. G., Spiro, S. G.
Publicado 1989

The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.

por Twelves, C. J., Souhami, R. L., Harper, P. G., Ash, C. M., Spiro, S. G., Earl, H. M., Tobias, J. S., Quinn, H., Geddes, D. M.
Publicado 1990

A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.

por Earl, H. M., Rudd, R. M., Spiro, S. G., Ash, C. M., James, L. E., Law, C. S., Tobias, J. S., Harper, P. G., Geddes, D. M., Eraut, D.
Publicado 1991

Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?

por Warren, R M L, Bobrow, L G, Earl, H M, Britton, P D, Gopalan, D, Purushotham, A D, Wishart, G C, Benson, J R, Hollingworth, W
Publicado 2004

A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial

por Provenzano, E, Vallier, A-L, Champ, R, Walland, K, Bowden, S, Grier, A, Fenwick, N, Abraham, J, Iddawela, M, Caldas, C, Hiller, L, Dunn, J, Earl, H M
Publicado 2013

tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmona...

por Wardley, A M, Hiller, L, Howard, H C, Dunn, J A, Bowman, A, Coleman, R E, Fernando, I N, Ritchie, D M, Earl, H M, Poole, C J
Publicado 2008

NEAT: National Epirubicin Adjuvant Trial – toxicity, delivered dose intensity and quality of life

por Earl, H M, Hiller, L, Dunn, J A, Bathers, S, Harvey, P, Stanley, A, Grieve, R J, Agrawal, R K, Fernando, I N, Brunt, A M, McAdam, K, O'Reilly, S, Rea, D W, Spooner, D, Poole, C J
Publicado 2008

Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

por Earl, H.M., Hiller, L., Dunn, J., Macpherson, I., Rea, D., Hughes-Davies, L., McAdam, K., Hall, P., Mansi, J., Wheatley, D., Abraham, J.E., Caldas, C., Gasson, S., O'Riordan, E., Wilcox, M., Miles, D., Cameron, D.A., Wardley, A.
Publicado 2021

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial

por Ali, H. R., Dariush, A., Thomas, J., Provenzano, E., Dunn, J., Hiller, L., Vallier, A.-L., Abraham, J., Piper, T., Bartlett, J. M. S., Cameron, D. A., Hayward, L., Brenton, J. D., Pharoah, P. D. P., Irwin, M. J., Walton, N. A., Earl, H. M., Caldas, C.
Publicado 2017

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negativ...

por Earl, H. M., Hiller, L., Dunn, J. A., Blenkinsop, C., Grybowicz, L., Vallier, A.-L., Gounaris, I., Abraham, J. E., Hughes-Davies, L., McAdam, K., Chan, S., Ahmad, R., Hickish, T., Rea, D., Caldas, C., Bartlett, J. M. S., Cameron, D. A., Provenzano, E., Thomas, J., Hayward, R. L.
Publicado 2017

Chemotherapy for ovarian cancer--a consensus statement on standard practice.

por Adams, M., A'Hern, R. P., Calvert, A. H., Carmichael, J., Clark, P. I., Coleman, R. E., Earl, H. M., Gallagher, C. J., Ganesan, T. S., Gore, M. E., Graham, J. D., Harper, P. G., Jayson, G. C., Kaye, S. B., Ledermann, J. A., Osborne, R. J., Perren, T. J., Poole, C. J., Radford, J. A., Rustin, G. J., Slevin, M. L., Smyth, J. F., Thomas, H., Wilkinson, P. M.
Publicado 1998

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised...

por Earl, H M, Hiller, L, Dunn, J A, Vallier, A-L, Bowden, S J, Jordan, S D, Blows, F, Munro, A, Bathers, S, Grieve, R, Spooner, D A, Agrawal, R, Fernando, I, Brunt, A M, O'Reilly, S M, Crawford, S M, Rea, D W, Simmonds, P, Mansi, J L, Stanley, A, McAdam, K, Foster, L, Leonard, R CF, Twelves, C J, Cameron, D, Bartlett, J MS, Pharoah, P, Provenzano, E, Caldas, C, Poole, C J
Publicado 2012